<?xml version="1.0" encoding="UTF-8"?>
<p id="p0110">A fragment screening has produced several crystal structures of fragments bound to SARS-CoV-2 M
 <sup>pro</sup>, including covalent modifiers of Cys145.
 <xref rid="b0505" ref-type="bibr">
  <sup>101</sup>
 </xref> While the majority of fragments bind to the active site, some bind near the dimer interface of SARS-CoV-2 M
 <sup>pro</sup>. These fragments may inform the development of small-molecule inhibitors that are not substrate-derived.
</p>
